LUPKYNIS
Live / Registered — Registered (as of 22 Jun 2021)
What this means for you
Registered since 22 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88672395
- Registration number
- 6397451
- Mark type
- Stylized text
- Filed
- 29 Oct 2019
- Published for opposition
- 10 Mar 2020
- Registered
- 22 Jun 2021
- Attorney of record
- Matthew R. Wilmot
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis, and focal segmental glomerulosclerosis
Owner
- Aurinia Pharmaceuticals Inc., Victoria, BC, CA
- Aurinia Pharmaceuticals Inc., Victoria, BC, CA
- Aurinia Pharmaceuticals Inc., Victoria, BC, CA
Prosecution history
- 22 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 18 May 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 May 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 05 May 2021 — USE AMENDMENT FILED
- 15 May 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 May 2021 — TEAS STATEMENT OF USE RECEIVED
- 10 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2020 — SOU EXTENSION 1 GRANTED
- 08 Oct 2020 — SOU EXTENSION 1 FILED
- 08 Oct 2020 — SOU TEAS EXTENSION RECEIVED
- 05 May 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2020 — PUBLISHED FOR OPPOSITION
- 19 Feb 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED